Clinical trial
Atomoxetine Treatment for ADHD and Marijuana Dependence
NCT00360269 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00360269 |
|---|---|
| Title | Atomoxetine Treatment for ADHD and Marijuana Dependence |
| Official title | Atomoxetine Treatment for ADHD and Marijuana Dependence |
| Lead sponsor | Medical University of South Carolina, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Marijuana Abuse, Attention Deficit Disorder With Hyperactivity |
| Intervention type | Drug, Procedure |
| Interventions | Atomoxetine, Motivational enhancement therapy, Placebo |
| Enrollment | 38 |
| Start date | Nov 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Aug 4, 2006 |
| Last update posted | Dec 30, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: